A preclinical-stage biotech company based in Italy, developing small molecule therapeutics that induce targeted protein ...

The US Food and Drug Administration (FDA) has approved Avmapki Fakzynja Co-pack (avutometinib capsules; defactinib tablets) ...

UK pharma major GSK (LSE: GSK) has unveiled full Phase III data showing its experimental drug linerixibat significantly ...

Sweden’s immune-oncology firm Alligator Bioscience today announced the successful completion of the manufacture of the first GMP drug product batch of its lead asset mitazalimab using a new improved ...

US regenerative medicine firm Forever Labs has formally spun out SuperShot as a standalone business, a move the company says ...

Sino-American biotech BeiGene (Nasdaq: ONC; HKEX 06160) today announced that the European Commission has approved Tevimbra ...

The European Commission (EC) has approved a Marketing Authorization (MA) for Tremfya (guselkumab) to treat adults with ...

Massachusetts-based PAQ Therapeutics, a biotech developing KRAS degraders for cancers lacking effective treatment options, ...

UK-based specialty pharma business Kelso Pharma has appointed Bee Koen Low as its first chief operating officer (COO).

As the US government, under President Donald Trump, is on the verge of announcing significant new tariffs on pharmaceutical ...

Japanese drugmaker Takeda (TYO: 4502) posted revenue of 4.58 trillion yen ($31.7 billion) for the fiscal year ended March 31, ...

Privately-held Italian firm Sibylla Biotech today announced the appointment of Dieter Weinand as chairman of its board of ...